Clinical Trials Browser

Interventional × Hand-Foot Syndrome × Breast × Clear all

NCT05165069 2026-02-02

The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome

Phase 3 Active not recruiting

Breast Neoplasms, Hand-Foot Syndrome

NCT06602167 2024-12-12

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome

Phase NA Recruiting

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Hand-Foot Syndrome

NCT05755646 2024-05-24

WIn-HFS

Phase NA Completed

Breast Neoplasms, Hand-Foot Syndrome

NCT05641246 2024-01-03

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

Phase 2 Completed

Breast Neoplasms, Hand-Foot Syndrome

NCT00751101 2020-10-05

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Phase 2 Terminated

24 enrolled 12 charts

Breast Neoplasms, Hand-Foot Syndrome

NCT01100463 2019-10-08

Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome

Phase 1/2 Completed

Breast Neoplasms, Hyaline Fibromatosis Syndrome, Hand-Foot Syndrome